Aplastic Anemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

FDA Approval in Myeloma, Breakthrough Designations in RCC and Aplastic Anemia, and More - OncLive



OncLive
 
FDA Approval in Myeloma, Breakthrough Designations in RCC and Aplastic Anemia, and More 
OncLive
The FDA has approved denosumab for the prevention of skeletal-related events in patients with multiple myeloma. The approval of the RANK ligand inhibitor is based on data from the phase III 482 study, which were presented at the 16th International ...

and more » 


Frontline Eltrombopag Receives FDA's Breakthrough Therapy Designation for Severe Aplastic Anemia - Targeted Oncology



Targeted Oncology
 
Frontline Eltrombopag Receives FDA's Breakthrough Therapy Designation for Severe Aplastic Anemia 
Targeted Oncology
Eltrombopag (Promacta) has been granted a breakthrough therapy designation by the FDA for use in combination with standard immunosuppressive therapy for the first-line treatment of patients with severe aplastic anemia (SAA). This designation will help ...
Severe Aplastic Anemia Drug Gets Breakthrough Designation Specialty Pharmacy Times
FDA Grants Promacta Breakthrough Therapy Designation for Aplastic Anemia Rare Disease Report
Novartis drug PromactaŽ receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia ... PR Newswire (press release)
Pharmacy Times  -MD Magazine  -Reuters 
all 12 news articles » 


Promacta Earns Breakthrough Therapy Designation by FDA for Severe Aplastic Anemia - AJMC.com Managed Markets Network



Promacta Earns Breakthrough Therapy Designation by FDA for Severe Aplastic Anemia 
AJMC.com Managed Markets Network
Promacta Earns Breakthrough Therapy Designation by FDA for Severe Aplastic Anemia. Samantha DiGrande. Recently, the FDA granted a breakthrough therapy designation to eltrombopag (Promacta, Novartis) for combination use with standard immunosuppressive ...

 


Gymnastics' Becky Carter Classic finding new purpose - News Sentinel



News Sentinel
 
Gymnastics' Becky Carter Classic finding new purpose 
News Sentinel
When the Concordia Invitational for gymnastics started in 1986, it as a way for then-Cadets coach Vicki Wright to showcase a young team that included Becky Carter who won the state balance beam title and the mental attitude award later that year. A few ...

 


Novartis' Promacta gets FDA breakthrough designation for severe ... - Pharmaceutical Business Review



Pharmaceutical Business Review
 
Novartis' Promacta gets FDA breakthrough designation for severe ... 
Pharmaceutical Business Review
Novartis' drug Promacta (eltrombopag) has secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for first-line treatment of severe aplastic anemia (SAA). Promacta can now be used in combination with standard ...

and more » 


Kent State athlete returns to school after bone marrow transplant - Akron Beacon Journal



Kent State athlete returns to school after bone marrow transplant 
Akron Beacon Journal
KENT: Antwan Dixon, a Kent State University football player who missed the last two seasons while undergoing a bone marrow transplant and chemotherapy, is returning to school this week, the Naples Daily News reports. Dixon, a 5-foot-8 receiver who ...

and more » 


City mourns 9-year-old's death - Gaston Gazette - Gaston Gazette



Gaston Gazette
 
City mourns 9-year-old's death - Gaston Gazette 
Gaston Gazette
The Cherryville community is mourning the loss of 9-year-old Glenn Jackson.Jackson died Sunday at Levine Children's Hospital in Charlotte after a more than year-long battle that began with a severe blood disorder.He was a fourth-grader at W.B. Beam ...
City mourns 9-year-old's death - Shelby Star Shelby Star

all 1 news articles » 


BloodCenter of Wisconsin in 'critical need' of blood - WXOW.com



BloodCenter of Wisconsin in 'critical need' of blood 
WXOW.com
"After a bone marrow biopsy, we found out that I have Severe Aplastic Anemia," she said. Severe Aplastic Anemia is an autoimmune disease that can lead to bone marrow failure. As a result, Simonson's red blood cells, white blood cells, and platelets ...

 


January 17 - Racer X Online



Racer X Online
 
January 17 
Racer X Online
... final 125 National standings while racing as a full privateer. Without an AMA ride, he decided to take an offer in Europe with Sylvain Geboers' Suzuki team alongside a young Stefan Everts. Schmit ended up winning the 1990 FIM 125cc Motocross World ...

 


Aplastic Anemia Market Disease Type, Consulting Services, Symptoms, Analysis and Forecast - GEOPOLMonitor



GEOPOLMonitor
 
Aplastic Anemia Market Disease Type, Consulting Services, Symptoms, Analysis and Forecast 
GEOPOLMonitor
Aplastic Anemia Market Global API Manufacturers, Marketed and Phase III Drugs Landscape, report provides comprehensive insights about marketed and Phase III products for the Aplastic Anemia Industry. The report includes information of marketed products ...

and more »